Science is Beautiful Blog

A Decade of Dedication to Supporting Breast Cancer: JFK Communications Displays Strong Values; Strong Traditions

Posted by John Kouten, CEO

Oct 14, 2014 2:43:00 PM

At JFK Communications, we have had the distinct honor and privilege of participating in the Central and South Jersey (CSNJ) Susan G. Komen (www.komencsnj.org) Race for the Cure (RFTC) for the past 10 years!

Read More

Topics: JFK Communications, Advocacy, Agency Culture, Breast cancer, Susan G. Komen for the Cure Central and South Jers

Patient Advocacy – Responsible and Strategic

Posted by John Kouten, CEO

Jul 10, 2012 5:16:00 PM

Read More

Topics: Healthcare communications, media relations, JFK Communications, impact of social media in healthcare, patient advocacy, Stupid Cancer, Sara Kouten

The JFK Download: The Importance of Company Culture

Posted by Michele Beyer

Feb 7, 2012 2:43:00 PM

Welcome to the next edition of The JFK Download - JFK Communications' video blog. In this episode, David Avitabile, President, JFK Communications, discusses the importance of company culture and provides insight into the type of culture we at JFK Communications strive to build and maintain.

Read More

Topics: JFK Communications, Culture, Agency Culture, Agency Management

The JFK Download: FDA & Social Media

Posted by Michele Beyer

Jan 20, 2012 5:20:00 PM

Welcome to The JFK Download - JFK Communications' video blog. This inaugural edition of The JFK Download, David Patti, Senior Vice President, JFK Communications, discusses the latest FDA Guidance, "Responding to to Unsolicited Requests for Off-label Information About Prescription Drugs and Medical Devices," and what implications this guidance has on the healthcare communications industry.

Read More

Topics: Healthcare communications, pharmaceutical, FDA, JFK Communications, Social media in pharma marketing, impact of social media in healthcare

Healthcare Reform and Pharmaceutical Marketers – Sweethearts?

Posted by John Kouten, CEO

Feb 14, 2011 2:14:00 PM

Read More

Topics: Healthcare communications, healthcare public relations, US pharmaceutical market, biotechnology and medical technology companies, personalized medicine, JFK Communications, healthcare reform

FDA Speak: Complex Molecules Are Not Biologics

Posted by John Kouten, CEO

Jul 26, 2010 2:47:00 PM

Could the recent FDA approval of a generic version of Lovenox (enoxaparin) be the beginning of approvals of other complex molecules?  We recall that the Biologics Price Competition and Innovation Act of 2009 found its way into the Health reform bill.  The Biologics Act provides a pathway for biosimilars, however, grants biologics innovator companies 12-years patent exclusivity (http://tiny.cc/ymnj1).   While biologics currently reside outside the current generics approval processes, it seems that “complex molecules” like enoxaparin do not.  The developers of the generic enoxaparin, Sandoz, division of Novartis, are hoping to win approval next for a generic version of the “complex mixture” Copaxone for the treatment of multiple sclerosis.  For more details on FDA’s position visit: http://tiny.cc/fvvve.  For more information regarding Sanofi’s position, read their July 23 statement here:  http://tiny.cc/zgib3.

Read More

Topics: biotechnology and medical technology companies, FDA, JFK Communications, biosimilars

JFK Communications Supports Komen Foundation

Posted by John Kouten, CEO

May 26, 2009 2:05:00 PM

JFK Communications provided public relations support for the seventh annual Spirit of Jane Rodney reception on Friday, May 10, 2009.  The event took place at Drumthwacket, the governor’s mansion in Princeton, NJ.  This fundraiser for breast cancer research and awareness helped honor local heroes who embody the spirit, fight and passion of Jane Rodney.  The event honored Kim Taylor, President, Centocor/Ortho Biotech, Corporate Excellence Award; Philip Kirstein, Individual Achievement Award and Laurie Schnitzlein, Survivor Award.

JFK Communications provides Susan G Komen for the Cure Central and South Jersey with pro bono public relations and marketing communications support.  We are privileged to have the opportunity to work with an organization committed to such a worthy cause.  Komen is a perfect organization for JFK Communications.  Our family, friends and employees have all been impacted by this dreaded disease.  Also, many of our clients are engaged in the fight against cancer and breast cancer.  

Anyone interested in learning more about the Susan G. Komen for the Cure of Central and South Jersey, please visit: www.komencsnj.org. You can also follow some of our support for Komen on our Twitter account http://twitter.com/pharmaprman.

Read More

Topics: JFK Communications, Breast cancer, Susan G. Komen for the Cure Central and South Jers

 

Most Popular

Recent Posts

Posts by tags

see all